Cargando…
Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients
CanAssist‐Breast (CAB) is an immunohistochemistry (IHC)‐based prognostic test for early‐stage Hormone Receptor (HR+)‐positive breast cancer patients. CAB uses a Support Vector Machine (SVM) trained algorithm which utilizes expression levels of five biomarkers (CD44, ABCC4, ABCC11, N‐Cadherin, and Pa...
Autores principales: | Bakre, Manjiri M., Ramkumar, Charusheila, Attuluri, Arun Kumar, Basavaraj, Chetana, Prakash, Chandra, Buturovic, Ljubomir, Madhav, Lekshmi, Naidu, Nirupama, R, Prathima, Somashekhar, S. P., Gupta, Sudeep, Doval, Dinesh Chandra, Pegram, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488210/ https://www.ncbi.nlm.nih.gov/pubmed/30848103 http://dx.doi.org/10.1002/cam4.2049 |
Ejemplares similares
-
Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
por: Attuluri, Arun Kumar, et al.
Publicado: (2019) -
Development of a Novel Proteomic Risk-Classifier for Prognostication
of Patients With Early-Stage Hormone Receptor–Positive Breast
Cancer
por: Ramkumar, Charusheila, et al.
Publicado: (2018) -
Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
por: Sengupta, Aditya K., et al.
Publicado: (2020) -
The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin
por: Chandra Doval, Dinesh, et al.
Publicado: (2021) -
CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario
por: Sankaran, Satish, et al.
Publicado: (2019)